Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of New Diagnostic Methods of Cardio-embolic Related (Atrial Fibrillation) Cerebral Infarction

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patient over 18~* Patient having a CHADS-VAsc Score ≥ 2;~* Patient hospitalized for a secondary established ischemic accident in an atrial fibrillation not anticoagulated (INR\<2 and/or receiving antiplatelet (aspirin, clopidogrel)) for less than 14 days;~* Patient affiliated to a national insurance scheme or beneficiary~* Patient having given a written consent~Exclusion Criteria:~* Patient presenting cognitive disorders incompatible with the planned examinations (MRI / SCANNER).~* Pacemaker or implantable defibrillator, or other contraindication in the MRI (metallic eye brightness, intra cerebral clip).~* Contraindication in injected scanner.~* Current pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Stroke (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).